Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB22FZW12
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $56,843
Award facts
- Contract value 100% obligated
- $56,842.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $56,842.80, is for the delivery of Entyvio 300 mg vials, a specialty pharmaceutical product.
The contract is part of a larger indefinite delivery contract (IDC) vehicle held by DMS Pharmaceutical Group with the DLA, valued at up to $499,999,999, which allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military healthcare facilities worldwide. This IDC, along with other prime vendor contracts held by DMS Pharmaceutical Group, solidifies the company's position as a crucial supplier in the federal pharmaceutical supply chain, providing both routine and critical medications to the Department of Defense.
The contract has no set-aside designation, but DMS Pharmaceutical Group's status as a woman-owned small business likely contributed to securing this award. The company's capabilities in delivering a wide array of pharmaceutical products, including branded, generic, and specialty drugs, as well as medical consumables, make it a valuable partner in supporting the recurring medical supply requirements of military healthcare facilities globally.
Quick answers
Who was awarded contract SPE2DB22FZW12?
SPE2DB22FZW12 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 9, 2022.
How much is contract SPE2DB22FZW12 worth?
The government has obligated $56,843 on SPE2DB22FZW12.
Is contract SPE2DB22FZW12 an order under another contract?
Yes. SPE2DB22FZW12 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB22FZW12 competed?
The extent of competition for SPE2DB22FZW12 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award